Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115283 · ClinicalTrials.gov registry record · NA

An Active Approach to Treat Amblyopia: Perceptual Learning and Video Games

A NA study, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT01115283: Completed NA study, sponsored by University of California, Berkeley.

NCT01115283 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01115283, a NA study, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

Primary Outcome

Improvement in amblyopic vision : visual acuity and stereoacuity

Interventions

  • BEHAVIORAL Perceptual learning
  • BEHAVIORAL Video Games
  • BEHAVIORAL Occlusion therapy

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2015-07
Est. Completion 2022-10-31
Phase NA
University of California, Berkeley

72 total trials

What the finished NCT01115283 record still lists

NCT01115283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Perceptual learning is the first listed.

NCT01115283 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01115283 about?

NCT01115283 is a clinical study titled "An Active Approach to Treat Amblyopia: Perceptual Learning and Video Games". Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

What is the current status of trial NCT01115283?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-07. Estimated completion is 2022-10-31.

What interventions are being tested in trial NCT01115283?

The interventions under investigation include: Perceptual learning (BEHAVIORAL), Video Games (BEHAVIORAL), Occlusion therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01115283?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01115283's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01115283, the US trial registry maintained by the National Library of Medicine. NCT01115283 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.